Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: Donald L. Elbert Clear advanced filters
  • Sleep-active physiological processes enhance overnight glymphatic clearance of Alzheimer’s disease biomarkers into plasma in humans, supporting the critical role of glymphatic function in Alzheimer’s pathophysiology and its potential as a therapeutic target.

    • Paul Dagum
    • Donald L. Elbert
    • Jeffrey J. Iliff
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-17
  • To understand if brain interstitial fluid/cerebrospinal fluid (ISF/CSF) exchange, CSF turnover, blood-brain barrier function or proteolysis were affected by aging or the presence of β amyloid plaques, Elbert et al. develop a non-steady state physiological model using MRI-derived brain volumes, stable isotope labeling kinetics of Aβ, and lumbar CSF Aβ concentration. Their model suggests an important role for blood-brain barrier transport and proteolytic degradation of Aβ in the development Alzheimer’s Disease in humans.

    • Donald L. Elbert
    • Bruce W. Patterson
    • Randall J. Bateman
    ResearchOpen Access
    Communications Biology
    Volume: 5, P: 1-13
  • Paterson and colleagues describe how stable isotope labelling kinetics (SILK) can be used to determine protein production and clearance rates. They highlight the promise of SILK studies for elucidating the role of pathogenic proteins in neurodegenerative diseases, including Alzheimer disease.

    • Ross W. Paterson
    • Audrey Gabelle
    • Randall J. Bateman
    Reviews
    Nature Reviews Neurology
    Volume: 15, P: 419-427